Literature DB >> 1426514

Management of eclampsia: cardiopulmonary arrest resulting from magnesium sulfate overdose.

J M Swartjes1, M F Schutte, O P Bleker.   

Abstract

An eclamptic seizure occurring at 32+2 weeks of gestation was treated with magnesium sulfate. Accidentally an overdose was given. As a consequence, the patient had a cardiopulmonary arrest. Immediate resuscitation and calcium gluconate administration did restore vital functions. Pregnancy continued for 4 weeks after the accident. Both mother and child left the hospital in good condition.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1426514     DOI: 10.1016/0028-2243(92)90217-m

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  3 in total

1.  Iatrogenic magnesium toxicity following intravenous infusion of magnesium sulfate: risks and strategies for prevention.

Authors:  Gillian F Cavell; Catherine Bryant; Seetal Jheeta
Journal:  BMJ Case Rep       Date:  2015-07-31

Review 2.  Role of magnesium sulfate in seizure prevention in patients with eclampsia and pre-eclampsia.

Authors:  J Anthony; R B Johanson; L Duley
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

Review 3.  Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review.

Authors:  Emily S Bain; Philippa F Middleton; Caroline A Crowther
Journal:  BMC Pregnancy Childbirth       Date:  2013-10-21       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.